HomeHealth articleshemolysisWhat Is Sucrose Hemolysis Test?

Sucrose Hemolysis Test - An Overview

Verified dataVerified data
0

4 min read

Share

The sucrose hemolysis test is a confirmatory test for paroxysmal nocturnal hemoglobinuria. Read the article below to know it in detail.

Medically reviewed by

Dr. Mubashir Razzaq Khan

Published At January 3, 2023
Reviewed AtFebruary 13, 2024

Introduction:

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of hematopoiesis (production of acellular components of blood cells) in which the red blood cells are abnormally sensitive to lysis by normal constituents of plasma. It is characterized by hemoglobinuria (high hemoglobin concentration in the urine) during sleep (nocturnal hemoglobinuria), jaundice, and hemosiderinuria. PNH is not a hereditary disease. It is an acquired condition that occurs due to variations in the PIG-A gene, which causes a deficiency of glycosylphosphatidylinositol-anchored proteins (GPI-AP) on the surface of hematopoietic stem cells.

What Is Sucrose Hemolysis Test?

Sugar-water hemolysis is a blood investigation done for the detection of fragile red blood cells. It determines the fragility of cells by testing their extent of swelling when immersed in a low-salt solution. The test may be recommended when there are manifestations of paroxysmal nocturnal hemoglobinuria or hemolytic anemia. Hemolytic anemia occurs due to the lysis of RBCs earlier than their normal lifespan, whereas, in paroxysmal nocturnal hemoglobinuria, RBCs get destroyed by the complement system of the body (which enhances the ability of antibodies). The symptoms include pale skin, tiredness, weakness, and dizziness. If left untreated, it can cause thrombosis (blood clots), chronic kidney disease, pulmonary hypertension, organ damage, and anemia.

What Are the Characteristic Features of Paroxysmal Nocturnal Hemoglobinuria (PNH)?

The characteristic features of cells belonging to the PNH are that they are deficient in several cell-membrane-bound proteins, including red cells. Such proteins are:

  • Acetylcholine esterase (an enzyme that catalyzes the breakdown of acetylcholine and other choline esters that function as neurotransmitters).

  • Neutrophil alkaline phosphatase (an enzyme present in white blood cells).

  • CD55 (decay-accelerating factor or DAF).

  • CD59 (prevents reactive lysis of membrane or MIRL).

CD55, CD59, and HRF play a role in the protection of the cell against complement-mediated damage. CD59 prevents the terminal complex formation of complement, and it is found that the deficiency of CD59 causes the complement sensitivity of PNH red cells.

PNH type III red cells result in a complete deficiency of CD59, and PNH type II red cells are only partially deficient, and it is this contrast that accounts for their varying sensitivities to complement attack.

PNH red cells are easily affected by complement lysis. This can be exhibited in vitro by certain tests, such as:

  • Sugar water test.

  • Sucrose lysis test.

  • The acidified-serum test [Ham test].

How Is Sucrose Hemolysis Test Performed?

First and foremost, to obtain a blood sample from the body, the antiseptic is applied to the skin. Then, with the help of a tourniquet in the upper arm, pressure occurs, and the veins swell with blood. A needle is then inserted into the vein to draw some amount of blood by the syringe, which is then stored in a vial. The sample is sent to the laboratory for its examination. Usually, the ratio of old RBCs to new RBCs can signify if any imbalance is present. However, rarely bone marrow biopsy is also advised, which includes getting a sample from bone marrow and analyzing it for abnormalities.

Reagents and types of equipment used for the test:

  • Specimen- Whole blood.

  • Volume- 1 ml.

  • Container- 7 mL ACD or lavender top (EDTA).

How Does the Sucrose Hemolysis Test Work?

Washed erythrocytes are incubated in an isotonic sucrose solution carrying normal ABO- compatible serum. In low ionic solution, red blood cells tend to absorb the components of complement from serum. As PNH erythrocytes have higher sensitivity than normal cells, they get hemolyzed (broken and dissolved blood cells) in this environment. The normal red blood cells do not undergo this change. After the completion of the incubation period, the mixture is looked for hemolysis.

What Are the Uses of the Sucrose Hemolysis Test?

Normal test results show that less than five percent of erythrocytes undergo lysis when tested. This phenomenon is known as hemolysis. Mostly, a normal test is not able to rule out paroxysmal nocturnal hemoglobinuria, and usually, a false normal result is obtained if the serum is deficient in complement or exhibits recent blood transfusions. The abnormal results of the test or positive results suggest that more than ten percent of RBCs go through lysis, thus concluding the presence of paroxysmal nocturnal hemoglobinuria in the patient.

How Is the Sucrose Hemolysis Test Measured?

The hemolysis reference range on sucrose hemolysis testing, including screening and confirmatory tests, is as follows:

Sucrose Hemolysis Test (Screening):

  • No Hemolysis Visible - Negative result.

  • Hemolysis Present - Positive result.

Sucrose Hemolysis Test (Confirmatory):

Hemolysis findings in the supernatant are as follows:

  • Less Than 5 % - Inconsequential or negative.

  • 6 to 10 % - Questionable or borderline.

  • More Than 10 % - Positive.

The reference range does not differ with parameters like age, gender, race, or ethnicity. However, the percentage of hemolysis on the sucrose hemolysis test can fluctuate depending on the temperature at which the investigation is carried out, the blood type used (defibrinated or whole blood), and the latest blood transfusions that dilute the presence of percentage of paroxysmal nocturnal hemoglobinuria (PNH) cells. So, the test must be performed at an appropriate temperature, with the optimal blood type and adequate history of recent blood transfusions to avoid false-positive and false-negative results, respectively.

What Does the Sucrose Hemolytic Test Result Mean?

Sucrose Hemolysis Test (Whole Blood Screening Test):

  • Positive Result - Hemolysis detected; further confirmatory test required.

  • Negative Result - No hemolysis.

Sucrose Hemolysis Test (Confirmatory):

  • Less Than 5 % Hemolysis - Inconsequential or negative.

  • 6 to 10 % Hemolysis - Borderline or questionable; found in some leukemia, aplastic anemia, autoimmune hemolytic anemia, megaloblastic anemia, and myelofibrosis.

  • More Than 10 % Hemolysis - Positive, diagnostic for paroxysmal nocturnal hemoglobinuria (results should be correlated with acid lysis or Ham test or flow cytometry); also found in congenital dyserythropoietic anemia type II.

Conclusion:

Hemolysis of five percent or less is considered negative within normal limits. Hemolysis of six to ten percent is thought to be borderline. Positive results will show greater than ten percent hemolysis. Increased hemolysis (less than ten percent) may be found in some patients with leukemia or myelofibrosis, whereas patients with PNH show ten percent to 80 % hemolysis (will only be as low as 370). The results of the sucrose hemolysis test should correlate with the acid serum test.

Frequently Asked Questions

1.

What Is the Test Used to Detect Sucrose Hemolysis in PNH?

The test used to detect sucrose hemolysis in PNH is known as the sucrose lysis test. It is a diagnostic assay that measures the sensitivity of red blood cells to the osmotic pressure created by a sucrose solution. This test helps identify the presence of paroxysmal nocturnal hemoglobinuria (PNH), a rare disorder characterized by abnormal red blood cell destruction.

2.

What Is the Underlying Principle of the Sucrose Lysis Test?

 
The sucrose lysis test operates on the principle that red blood cells with heightened sensitivity to osmotic pressure will undergo hemolysis in a sucrose solution. This principle enables the differentiation between normal red blood cells and those impacted by conditions like paroxysmal nocturnal hemoglobinuria (PNH), where cells are more prone to lysis.

3.

How Is Hemolysis Tested?

 
Hemolysis is tested by assessing the release of hemoglobin from red blood cells. Various methods can be employed, including measuring free hemoglobin levels or using specific assays to detect markers of hemolysis. These tests help evaluate the extent and presence of red blood cell destruction in different conditions.

4.

What Is the Purpose of the Sucrose Hemolysis Test?

 
The sucrose hemolysis test aims to identify the presence of paroxysmal nocturnal hemoglobinuria (PNH). By assessing the sensitivity of red blood cells to a sucrose solution, the test helps determine if the cells are more prone to hemolysis, a characteristic feature of PNH. This test aids in the diagnosis and evaluation of this rare blood disorder.

5.

What Does a Positive Sucrose Test Indicate?

 
A positive sucrose test indicates red blood cells are more susceptible to hemolysis in a sucrose solution. This can suggest the presence of conditions such as paroxysmal nocturnal hemoglobinuria (PNH), where abnormal red blood cells are prone to destruction. A positive result in the sucrose test helps confirm the diagnosis of PNH and assess the severity of the condition.

6.

What Is Considered the Gold Standard Test for Diagnosing PNH?

 
Flow cytometry using antibodies targeting CD55 and CD59 is the gold standard test for diagnosing paroxysmal nocturnal hemoglobinuria (PNH). This test detects deficient or absent expression of these proteins on the surface of red blood cells and other blood cell types. Flow cytometry provides a reliable and accurate method for PNH diagnosis and assessment of the size of PNH cell populations.

7.

Why Does the Coombs Test Yield a Negative Result in PNH?

 
The Coombs test yields a negative result in PNH because PNH is not an immune-mediated hemolytic disorder. The underlying cause of PNH is a genetic mutation affecting glycosylphosphatidylinositol (GPI) anchors on the surface of red blood cells, which is different from the immune-related mechanisms targeted by the Coombs test. Therefore, the Coombs test detects immune-mediated hemolysis and does not show positive results in PNH cases.

8.

What Are the Three Types of Hemolysis?

The three types of hemolysis are classified as follows:
- Alpha hemolysis: Partial hemolysis resulting in a greenish discoloration around the colonies on a plate.
- Beta hemolysis: Complete hemolysis causes a clear zone around the colonies on a blood agar plate.
- Gamma hemolysis: No hemolysis occurs, and there is no change in the appearance of the blood agar plate surrounding the colonies.

9.

What Is the Normal Level of Hemolysis?

 
There is no specific "normal" level of hemolysis, as it can vary depending on the context. In a healthy individual, the level of hemolysis is typically minimal and does not lead to significant release of hemoglobin into the bloodstream. However, excessive or pathological hemolysis can result in an abnormal increase in free hemoglobin and related clinical manifestations. Hemolysis levels are evaluated through specific tests and clinical assessment rather than relying on a predefined "normal" range.

10.

Is Hemoglobin Elevated or Reduced in Cases of Hemolysis?

 
In cases of hemolysis, hemoglobin levels are typically elevated. Hemolysis involves the breakdown of red blood cells, leading to the release of hemoglobin into the bloodstream. This increased release of hemoglobin can result in elevated levels, which can be measured through laboratory tests. Monitoring hemoglobin levels helps assess the extent and severity of hemolysis in various conditions.

11.

Can a Complete Blood Count (CBC) Detect Hemolysis?

 
Yes, a complete blood count (CBC) can provide indirect indications of hemolysis. The CBC includes parameters such as hemoglobin levels, red blood cell count, and hematocrit, which can show abnormalities suggestive of hemolysis, such as decreased hemoglobin, reduced red blood cell count, and low hematocrit. However, a CBC alone cannot confirm the presence of hemolysis definitively, and further tests, such as assessing reticulocyte count or direct measurement of markers of hemolysis, may be necessary for a comprehensive evaluation.

12.

What Are the Treatment Options for Hemolysis?

The treatment options for hemolysis depend on the underlying cause and severity of the condition. Management aims to address the cause, control symptoms, and prevent complications. Treatment approaches may include addressing underlying infections or autoimmune disorders, blood transfusions to replace damaged red blood cells, immunosuppressive therapy to suppress the immune system, or, in severe cases, splenectomy to remove the spleen, which can be involved in the destruction of red blood cells. Individualized treatment plans are determined based on the specific needs of each patient.

13.

Which Test Can Be Utilized to Identify Hemolytic Conditions?

 
The test commonly used to identify hemolytic conditions is the direct antiglobulin test (DAT), also known as the Coombs test. This test detects the presence of antibodies or complement proteins on the surface of red blood cells, indicating immune-mediated hemolysis. By identifying these antibodies or complement proteins, the DAT helps diagnose and differentiate various hemolytic disorders, such as autoimmune hemolytic anemia and drug-induced hemolytic reactions.
Source Article IclonSourcesSource Article Arrow
Dr. Mubashir Razzaq Khan
Dr. Mubashir Razzaq Khan

Hematology

Tags:

sucrose hemolysis testhemolysis
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

hemolysis

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy